Group Leader/s
Group PI/s
intro
My laboratory currently has three major research goals:
- To understand the role of mitochondria-associated ER membranes (MAM) in the overall lipid homeostasis of neurons.
- To understand whether perturbations in mitochondria-associated ER membranes (MAM) and lipid signaling underlie synaptic dysfunction and/or neuronal death in various disorders, including Alzheimer's disease and Amyotrophic Lateral Sclerosis.
- To identify lipid biomarkers that either segregate with or predict clinical outcomes of neurological disorders, such as Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis and Down syndrome.
To tackle these fundamental questions, my lab employs multidisciplinary approaches, which range from molecular and cell biology, protein, and lipid biochemistry (including state-of-the-art ‘lipidomics’-based approaches) to mouse genetics and behavioral assessments of genetically-modified mice.
In the last decade, our concept of cell architecture has progressively changed, from the classic image where the different organelles were floating independently in the cytosol, to a cell where all the organelles interact with each other, forming functional contact sites. in membranes [3]. These membrane-to-membrane contacts are proposed in the field as a form of communication between different organelles and with previously unsuspected relevance to cell function. For example, functions such as the calcium transport, the regulation of lipid synthesis and transport or the formation of autophagosomes are located in areas of contact between organelles such as the ER, mitochondria, Golgi or peroxisomes [3].
One of the most studied interactions in the field is what happens between the endoplasmic reticulum (ER) and mitochondria, whose contact results in the formation of cholesterol-rich domains (or lipid-rafts) in the ER, called MAMs (mitochondria associated membranes).
![]() |
Among other functions, MAM has been related to the synthesis of phospholipids, cholesterol transport and regulation of glucose metabolism and calcium transport [5-8].
The study of the role of MAM in cell regulation has expanded remarkably in the last 5 years with numerous works focused on the study of the protein composition of MAM or the generation of genetic tools to induce union of both organelles [9]. On the other hand, the role of MAM in metabolic and neurodegenerative diseases such as diabetes or Alzheimer's disease (ALZ) or amyotrophic lateral sclerosis (ALS), has aroused new interest in the field [11,12].
My work as a postdoctoral researcher in the laboratory of Dr. Schon at Columbia University was one of the first to link defects in MAM regulation and ER-mitochondrial contacts in ALZ [13-15]. Continuing my laboratory's line of research, my objective is to focus on the cause and consequences of MAM regulation defects, as well as the impact of lipid alterations on neuronal and inflammatory function in the context of neurodegenerative diseases such as ALZ and ALS.
- Pera, M., et al., Increased localization of APP-C99 in mitochondria-associated ER membranes causes mitochondrial dysfunction in Alzheimer disease. EMBO J, 2017. 36(22): p. 3356-3371.
- Montesinos, J., et al., The Alzheimer's disease-associated C99 fragment of APP regulates cellular cholesterol trafficking. EMBO J, 2020: p. e103791.
- Scorrano, L., et al., Coming together to define membrane contact sites. Nat Com., 2019. 10(1): p. 1287.
- Marquer, C., et al., Increasing membrane cholesterol of neurons in culture recapitulates Alzheimer's disease early phenotypes. Mol Neurodegener, 2014. 9: p. 60.
- Herrera-Cruz, M.S. and T. Simmen, Over Six Decades of Discovery and Characterization of the Architecture at Mitochondria-Associated Membranes (MAMs). Adv Exp Med Biol, 2017. 997: p13-31.
- Herrera-Cruz, M.S. and T. Simmen, Of yeast, mice and men: MAMs come in two flavors. Biol Direct, 2017. 12(1): p. 3.
- Raturi, A. and T. Simmen, Where the endoplasmic reticulum and the mitochondrion tie the knot: the mitochondria-associated membrane (MAM). Biochim Biophys Acta, 2013. 1833(1): p. 213-24.
- Rieusset, J., Mitochondria-associated membranes (MAMs): An emerging platform connecting energy and immune sensing to metabolic flexibility. Biochem Biophys Res Commun, 2018. 500(1): p. 35-44.
- Hung, V., et al., Proteomic mapping of cytosol-facing outer mitochondrial and ER membranes in living human cells by proximity biotinylation. Elife, 2017. 6.
- Xia, M., et al., Communication between mitochondria and other organelles: a brand-new perspective on mitochondria in cancer. Cell Biosci, 2019. 9: p. 27.
- Area-Gomez, E. and E.A. Schon, Mitochondria-associated ER membranes and Alzheimer disease. Curr Opin Genet Dev, 2016. 38: p. 90-96.
- Watanabe, S., et al., Mitochondria-associated membrane collapse is a common pathomechanism in SIGMAR1- and SOD1-linked ALS. EMBO Mol Med, 2016. 8(12): p. 1421-1437.
- Area-Gomez, E., et al., Presenilins are enriched in endoplasmic reticulum membranes associated with mitochondria. Am J Pathol, 2009. 175(5): p. 1810-6.
- Area-Gomez, E., et al., Upregulated function of mitochondria-associated ER membranes in Alzheimer disease. EMBO J, 2012. 31(21): p. 4106-23.
- Schon, E.A. and E. Area-Gomez, Is Alzheimer's disease a disorder of mitochondria-associated membranes? J Alzheimers Dis, 2010. 20 Suppl 2: p. S281-92.
Members
Estela Area Gomez |
Jorge Montesinos Selfa |
Nuria Gomez Lopez |
Monica Mª Uceda Gonzalez |
Taekyung Daniel Yun |
Cristina Anton Barros |
Lorena Rodriguez Bravo |
Carlos Sanz Garcia |
Selected Publications
Area-Gomez E*, Larrea D, Yun T, Xu Y, Hupf J, Zandkarimi F, Chan RB, Mitsumoto H. [2021]. Lipidomics study of plasma from patients suggest that ALS and PLS are part of a continuum of motor neuron disorders. Sci Rep. 2021 Jun 30;11(1):13562. doi: 10.1038/s41598-021-92112-3. PMCID: PMC8245424. PMID: 34193885.
Montesinos J. Pera M. Larrea D., Guardia-Laguarta C, Agrawal R.R., Velasco KR, Yun D., Stavrovskaya I, XU Y., Koo Y., Snead AM., Sproul AA., Area-Gomez E. [2020]. The Alzheimer's disease-associated C99 fragment of APP regulates cellular cholesterol trafficking EMBO J. 2020 Oct 15;39(20):e103791. doi: 10.15252/embj.2019103791. Epub 2020 Aug 31. PMCID: PMC7560219. PMID 32865299
Montesinos J, Guardia-Laguarta C, Area-Gomez E [2020]. The Fat Brain. Curr Opin Clin Nutr Metab Care . 2020 Mar;23(2):68-75. doi: 10.1097/MCO.0000000000000634. PMID: 32004239.
Pera M, Montesinos J, Larrea D, Agrawal RR, Velasco KR, Stavrovskaya IG, Yun TD, Area-Gomez E [2020]. MAM and C99, key players in the pathogenesis of Alzheimer's disease. (2020). Int Rev Neurobiol. 2020;154:235-278. doi: 10.1016/bs.irn.2020.03.016. Epub 2020 Jul 22. PMID: 32739006.
Area-Gomez, E*., Larrea, D., Guilfoyle. D.N., Pirhaji. L., Agrawal R.R., Shannon. K, Arain. H., Ashok. A., Pera. M., Chen Q., Dillman. A.A., Figueroa. H., Cookson M.R., Gross S.S., Fraenkel E., Duff. K.E, Nuriel. T. [2020]. APOE4 is Associated with Differential Regional Vulnerability to Bioenergetic Deficits in Aged APOE Mice. Scientific reports. 2020 Mar 9;10(1):4277. doi: 10.1038/s41598-020-61142-8. PMCID: PMC7062695. PMID: 32152337.
Area-Gomez E, Guardia-Laguarta C, Schon EA, Przedborski S [2019]. Mitochondria, OxPhos, and neurodegeneration: cells are not just running out of gas. J Clin Invest. 2019 Jan 2;129(1):34-45. doi: 10.1172/JCI120848. Epub 2019 Jan 2. PMCID: PMC6307938. PMID: 30601141.
Area-Gomez E, de Groof A, Bonilla E, Montesinos J, Tanji K, Boldogh I, Pon L, Schon EA [2018]. A key role for MAM in mediating mitochondrial dysfunction in Alzheimern disease. Cell Death Dis. 2018 Feb 28;9(3):335. doi: 10.1038/s41419-017-0215-0. PMCID: PMC5832428. PMID: 29491396
Pera M, Larrea D, Guardia-Laguarta C, Montesinos J., Velasco KR, Agrawal RR, Xu Y., Chan RB, Di Paolo G., Mehler MF, Perumal GS, Macaluso FP Freyberg ZZ, Acin-Perez R, Enriquez JA, Schon EA, Area-Gomez E. [2017]. Increased localization of APP-C99 in mitochondria-associated ER membranes causes mitochodrial dysfunction in Alzheimer disease. EMBO. J 2017 Nov 15;36(22):3356-3371. doi: 10.15252/embj.201796797. Epub 2017 Oct 10. PMCID: PMC5731665. PMID: 29018038
Area-Gomez E. and Schon EA [2017]. Alzheimer’s disease. Adv. Exp. Med. Biol. 2017;997:149-156. doi: 10.1007/978-981-10-4567-7_11. PMID: 28815528.
Area-Gomez E. and Schon EA [2017]. On the Pathogenesis of Alzheimer’s disease: The MAM hypothesis. FASEB J. 2017 Mar;31(3):864-867. doi: 10.1096/fj.201601309. PMCID: PMC6191063. PMID: 28246299.
Area-Gomez E, Schon EA [2016]. Mitochondria-associated ER membranes and Alzheimer disease. Curr Opin Genet Dev. 2016 Jun;38:90-96. doi: 10.1016/j.gde.2016.04.006. Epub 2016 May 25. PMCID: PMC5390896. PMID: 27235807.
Area-Gomez E [2014]. Assessing the function of mitochondria-associated ER membranes (2014). Meth. Enzymol. 2014;547:181-97. doi: 10.1016/B978-0-12-801415-8.00011-4. PMID: 25416359.
Area-Gomez E, Schon EA [2014]. Mitochondrial genetics and disease (2014). J. Child Neurol. 2014 Sep;29(9):1208-15. doi: 10.1177/0883073814539561. Epub 2014 Jul 14. PMID: 25028417.
Schon EA, Area-Gomez E [2013]. Mitochondria-associated ER membranes in Alzheimer disease. Mol. Cell. Neurosci. 2013 Jul;55:26-36. doi: 10.1016/j.mcn.2012.07.011. Epub 2012 Aug 24. PMID: 22922446.
Area-Gomez E, Lara Castillo MdC, Tambini MD, de Groof AJC, Madra M, Ikenouchi J, Umeda M, Bird TD, Sturley SL, Schon EA. [2012]. Upregulated function of mitochondria-associated ER membranes in Alzheimer disease. EMBO J. 2012 Nov 5;31(21):4106-23. doi: 10.1038/emboj.2012.202. Epub 2012 Aug 14. PMCID: PMC3492725. PMID: 22892566
Funding
Generación de Conocimiento 2021.
PID2021-126818NB-I00. 235532. Regulation of mitochondria-associated membranes by the C99aa c-terminal domain of the amyloid precursor protein: relevance for Alzheimer’s Disease
- IP: E. Area Gomez
- Entidad: Ministerio de Ciencia e Innovación.
- Fecha de inicio y finalización: Sept 22-Agt 2025
Phospolipidomic of Astrocytes Microvesicles in AD Brains of Humans and Mouse Models: Lighting Taupathogenesis, Autophagy and New biomarkers.
- IP: Gloria Patricia Cardona Gomez
- Entidad: Universidad de Antioquia. Colombia.
- Fecha de inicio y finalización: 07/01/20-06/30/25
Differential neuronal susceptibility as an avenue toward disease-modifying therapy for Parkinson.
- IP: Area-Gomez, Estela
- Entidad: Parkinson’s disease Fundation.
- Fecha de inicio y finalización: 07/01/19-06/30/24
Proyecto Intramural (CSIC)
Ref. 202220E087 Autofagia y membranas asociadas a mitocondrias (MAMs).
- IP. E. Area Gomez.
- Fecha de inicio y finalizacion: Sept 22-Agt 2023.
Analysis of the lipid composition of plasma from ALS patients.
- IP: Area-Gomez, Estela
- Entidad: Project ALS Therapeutics Core.
- Fecha de inicio y finalización: 07/01/19-06/30/23.
- NIH R01 AG056387-01 : Role of C99 in the regulation of lipid metabolism- Relevance to Alzheimer's disease.
- IP: Area-Gomez, Estela
- Entidad: NIH. National Institutes of Health
- Fecha de inicio y finalización: 09/01/17-08/30/22.
- Role of mitochondria-ER membranes alteration in the pathogenesis of ALS.
- IP: Area-Gomez, Estela
- Entidad: Target ALS
- Fecha de inicio y finalización: 04/01/19-03/31/22.
- Analysis of the lipid composition of plasma from Alzheimer’s patients.
- IP: Area-Gomez, Estela
- Entidad: IP group venture capitalists.
- Fecha de inicio y finalización: 01/01/18-05/31/21
More info
2023 | Workshop on MCS in Biology and Disease. Baeza, España (Nov.2023) |
2020 | UMDF Mitochondrial medicine. Phoenix, U.S (cancelada hasta el 2021) |
2020 | FASEB "Phospholipid dynamics in health and disease". Colorado, U.S (Cancelada hasta el 2021) |
2020 | New York Academy of Sciences "Mitochondria in Complex disorders". New York, U.S (online) |
2020 | Alzheimer's research UK meeting. Wales (cancelada hasta el 2021) |
2019 | International Academy of Neurobiology. Dubai |
2019 | SEBC Sociedad Española de Biología Celular. Badajoz. |
2019 | International PLS Conference in Primary Lateral Sclerosis. Philadelphia. |
2018 | China Circle meeting. Clinical Nutrition in China: "Novel approaches for the next decades". Shangai y Beijing. |
2018 | EMBO Conference. Membrane contact sites in health and disease. Suiza. (Septiembre) |
2017 | FASEB conference. Mitochondrial biogenesis and dynamics in health and disease. West Palm Beach, Florida. |
2019-2022 | Miembro del Comité de selección del programa de doctorado en Metabolismo Celular, Columbia University. |
Desde 2016 | Miembro del tribunal de más de 10 tesis doctorales en activo. |
Desde 2013 | Mentora y Co-mentora de 4 tesis doctorales en activo. |
Desde 2013 | Mentora y Co-mentora de 5 postdoctorales. |
2013-2022 | Profesora del programa de doctorado en Metabolismo Celular. Columbia University. |
Desde 2019 | Editora de la revista Frontiers in Neuroscience. |
Desde 2017 | Revisora científica para el NIH "Emphasis panel National Institute of Aging" |
Desde 2017 | Revisora científica para el NIH "Neural Oxidative Metabolism, Mitochondria and cell death" |
Desde 2017 | Revisora científica de la Alzheimer's Association (EMBO J., Ann of Neuro., J. of Neuros., etc) |
Desde 2010 | Miembro de la Sociedad de Neurociencia. |